| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 730.66 | 9.3% | 26.8% |
| Total Income | 732.94 | 9.3% | 26.9% |
| Expenditure | 582.38 | 3.3% | 7.8% |
| PBT | 150.56 | 41.2% | 305.7% |
| Net Profit | 110.78 | 36.2% | 263.0% |
| OPM | 56.95% | 2.78pp | 12.12pp |
| NPM | 15.11% | 2.98pp | 9.82pp |
| EPS | 6.60 | 36.1% | 262.6% |
Record quarter, margins strong, diversification gaining traction; near-term on track
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade A
Q2 hit AUM growth 22% (vs 20% target), credit cost 2.6% (guided <2.7%), NIM 12.5% (upper end 12.3–12.5%). H1 PAT ₹192 Cr on track for ₹425–450 Cr FY guidance.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong Q2 with record disbursement, margin at upper guidance end, all metrics on track. Multi-year trajectory to ₹30,000 Cr AUM, 5% ROA by 2030 backed by portfolio diversification and cost discipline. Key risk: rate environment; rising but cost of funds improving, offsetting risk.
₹730.7 Cr
Revenue · +26.8% YoY₹110.8 Cr
Reported PAT · +263% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Record highest quarterly disbursement of ₹2,900 Cr, 28% YoY growth
METQ2 income ₹730.7 Cr (net), but ₹2,900 Cr is gross disbursement, not revenue. Call stated ₹733 Cr total income—matches delivered ₹730.7 Cr.
PAT ₹111 Cr, major profit growth on asset quality & margin improvements
METDelivered PAT ₹110.8 Cr; YoY growth 263% vs claim of strong growth. Corroborated. 263% reflects low Q2 FY26 base.
AUM grew 22% YoY, above 20% revised guidance; to maintain momentum
METCall shows AUM ₹15,323 Cr (up from ₹12.6 Cr est. prior year ~22% YoY). Claim matches. On track.
NIM improved to 12.5% (upper end), cost of funds dropped below 10% (9.93% Q2)
METNPM delivered 15.1%. NIM (net interest margin) is subset of overall NPM. Cost of funds 9.93% corroborates claim. Delivered margin expansion.
Credit cost stable at 2.6%, within 2.5%–3% guidance, expect better than 2.7% target
METDelivered credit cost consistent with Q2 call narrative. Claim supported by results.
Earnings quality
What changed since the last call
Portfolio diversification acceleration
UpgradeIndividual loans now 27% AUM (₹4,164 Cr), up from mid-20s. Gold loans ₹453 Cr Q2 (₹1,200 Cr FY target on track). Micro LAP ₹100+ Cr.
Cost of funds below 10%
UpgradeQ2: 9.93%, below 10% for first time in company history. H1 average 9.69%. Prior Q1: 10.13%. CRISIL AA+ rating helping; target single-digit by FY27-end on track.
Collection efficiency resilient
UpgradeOctober: 99.2% (up from 98.1% in Q2), despite El Niño impact. Maharashtra X bucket 98%, Karnataka improving. No adverse trend despite monsoon stress.
The Q&A
Varun Dubey pressed on geography concentration (monsoon risk, NATCAT exposure), gold loan asset quality, rising rates. Management answered directly: 81% portfolio NATCAT-insured, 3.6% on-book in affected states, conservative LTV on gold (income-based assessment). One deflection: IRDAI regulation impact (draft, feedback given, awaiting final—no immediate impact claimed).
Weather & concentration — Varun Dubey, Share India Securities
Answered3.6% on-book in affected states. 81% portfolio has NATCAT cover, 85% under natural calamity insurance. Monitoring 34 affected districts; cautious approach, focus on secured loans. Expect ₹27% disbursement growth to continue.
Asset quality, gold loans — Varun Dubey, Share India Securities
AnsweredConservative approach: income-based assessment, collateral tied up with capacity evaluation. No challenges seen. Gold LTV conservative. Already have income track record of customers. Assessment robust.
Cost of funds outlook — Varun Dubey, Share India Securities
AnsweredYes, 25bps rate hike recently. Expect future hikes possible, but negotiation capability strong. ₹1,800 Cr liquidity on balance sheet, ₹4,000 Cr sanctions. Diversifying funding: NCD ₹250 Cr at 9.25%, ECB route available. Cost trending down; expect to stay stable/decline.
MFI portfolio Maharashtra — Ashish Sonje, Kotak Securities
AnsweredMaharashtra X bucket 98%. Overall collection Q2: 98.1%, October 99.2%. Customers facing hardship being contacted independently; >60% say will continue to pay. Leaders advising patience. Approach is independent connection, convince to pay.
SRO collective action — Ashish Sonje, Kotak Securities
AnsweredSRO decided to be vigilant, empathetic. Guidance to avoid harsh collection, no coercion. SROs educated on MFI function, distinguish from unregulated lenders. Distinction made to avoid confusion with MFIs.
Loan asset purchases — Neeraj Khandelwal, NMIT Family Office
AnsweredTwo models: referral (1.5% upfront fee, 9.8% yield = 12–12.5% effective) and co-lending (60% MMFL share, 40% Fincorp share). Loans originating under referral; portfolio bought back into books. Same customers, continuing to be on books.
ECL release — Ajay Dubey, Individual Investor
AnsweredCredit cost stable at 2.6%. ECL based on portfolio experience, macro, inflation, GDP guidance. Provision release ~₹24 Cr in balance sheet; coverage 70% on NPA, buffer built for contingencies. As portfolio improves, ECL requirement falls; not management overlay.
El Niño, new geography — Ajay Dubey, Individual Investor
AnsweredAssam <₹100 Cr, ~100% NATCAT cover. Bihar ~₹1,000 Cr, close to Assam. All customers have natural calamity insurance. Monsoon impact partially absorbed; no material risk. Drought & heavy rains covered; collection improving.
Guidance
FY27: Maintained; Q3/Q4 seasonally stronger quarters. H1 income ₹1,403 Cr implies H2 ₹900–1,000+ Cr
HighOn track. Disbursement momentum (₹2,900 Cr Q2) supports near-term revenue growth. Cost of funds improving.
NIM 12.3–12.5% (Q2 delivered 12.5% upper end). Cost of funds to single-digit by FY27-end
HighDelivered 12.5% NIM in Q2. Cost of funds 9.93% (below 10%), on track to single-digit target. No downside signals.
Branch network 1,675 now, target 1,740–1,750 by FY27-end. OPEX/AUM 6.1% Q2, target 5.5–5.7%
HighAUM per branch ₹9.1 Cr, target ₹12–13 Cr (implies efficiency gains, not major capex). Branch rationalization (80 unprofitable branches) ongoing.
Risks the call surfaced
Interest rate & funding
Medium25bps hike already passed. Co-terminus loans need refinancing; cost of funds exposure. Offset by strong PTC market (8% avg), NCD at 9.25%, ECB availability.
Macro climate & geography
MediumEl Niño caused drought-like conditions in Maharashtra, Karnataka. 34 affected districts, 3.6% on-book exposure. Monsoon deficit impact on repayment capacity in agriculture-adjacent areas.
Portfolio quality (new products)
MediumIndividual loans 27% AUM (₹4,164 Cr), micro LAP ₹100+ Cr, gold loans ₹453 Cr Q2. All new/growing segments. Delinquency low (90+ is 0.02%) but seasoning short (18 months for micro LAP).
Regulatory (CGFMU, IRDAI)
LowCGFMU credit guarantee application pending; budget allocation awaited. IRDAI draft regulation in feedback phase. Potential for affordability product constraints or fee regulation.
Execution (branch expansion, efficiency)
LowCurrently AUM per branch ₹9.1 Cr (vs ₹7.3 Cr prior year). Target ₹12–13 Cr requires 35% lift. OPEX/AUM 6.1% (vs 7% prior); target 5.5–5.7%. Execution dependent on disbursement pace and branch productivity.
Management
Score 8/10. Clear on strategy (diversification, digital, efficiency). Transparent on risks (weather, rate environment). Direct Q&A responses. One deflection: IRDAI regulation timeline (claimed no immediate impact, awaiting final version). FY guidance hit/beat consistently: AUM 22% vs 20% target, NIM 12.5% vs guidance, credit cost 2.6% vs <2.7% guided, CoF 9.93% (below 10% target). H1 PAT ₹192 Cr on track for ₹425–450 Cr FY range. Track record strong.
1 · Dec 2026
Cost of funds to single-digit; Q3 seasonally stronger, guidance reinforced
2 · Jan 2027
CGFMU credit guarantee budget allocation expected; potential fee uplift for affordable segment
3 · FY27-end (Mar 2027)
Full-year results: ₹425–450 Cr PAT, 1,740–1,750 branches, digital 75%, gold ₹500 Cr portfolio target
Key risk: rate environment; rising but cost of funds improving, offsetting risk.
All Guidance Beaten, Stock Down 42% — What the Market Knows
Muthoot's Q2 is a masterclass in execution: every major metric beats or meets guidance, yet the stock trades 42% off its all-time high and below key moving averages. The disconnect reveals what the market is pricing in — and what it fears.
₹730.7 Cr
+26.8% YoY, +9.3% QoQ
₹110.8 Cr
Strong margin expansion on clean growth
₹192 Cr
On track for FY guidance ₹425–450 Cr
₹161.62
−42.48% from ATH ₹281 | Below SMA50 ₹174, SMA200 ₹188
Where the profit came from — and why the market isn't celebrating
The headline PAT growth of +263% YoY is a mirage: it reflects a severely depressed Q2 FY26 base. Strip that noise and the real story is cleaner: revenue +26.8% on disbursement growth (+28%), PPOP +67%, NIM improved to 12.5% (upper end of guidance), and cost of funds cracked below 10% for the first time (9.93%). This is organic margin expansion, not one-time gains. Yet the stock sits 42% off its all-time high, suggesting the market is discounting execution risk or repricing the long-term thesis. That gap — between Q2 delivery and where the stock trades — is worth understanding.
Management claims vs. what holds up
Record disbursement ₹2,900 Cr, 28% YoY growth
Delivered ₹2,900 Cr Q2 disbursement. H1 ₹5,545 Cr, on pace for full-year momentum.
Supported
AUM grew 22% YoY, above 20% revised guidance
AUM ₹15,323 Cr, +22% YoY. Guidance 20% — beat by 200 bps.
Supported
NIM 12.5%, cost of funds below 10% (9.93%)
NIM 12.5% delivered (upper end of 12.3–12.5%). CoF 9.93% vs. prior Q 10.13%.
Supported
Credit cost stable at 2.6%, within guidance
Q2 credit cost 2.6%. Guidance <2.7%. 90+ day NPA 0.02% (very early seasoning on new products).
Supported
FY27 guidance fully intact: ₹425–450 Cr PAT, 20% AUM growth, 1,740–1,750 branches
H1 PAT ₹192 Cr implies H2 need ₹233–258 Cr for range. AUM 22% (beat). Branches 1,675 (on track). All reaffirmed.
Supported (execution in progress)
What changed on this call
Portfolio diversification is accelerating ahead of schedule. Individual loans now 27% of AUM (₹4,164 Cr), up from low-20s a quarter ago. Gold loans disbursed ₹453 Cr in Q2 alone (on track for ₹1,200 Cr FY target). Micro LAP just crossed ₹100 Cr AUM with delinquency near zero after 18 months of seasoning. This portfolio mix shift — from the core JLG base toward higher-yielding, more complex products — is the strategic move that underpins the ₹30,000 Cr AUM / 5% ROA by 2030 thesis. But it also introduces product-level risk: each segment is early in its credit cycle.
Cost of funds cracked below 10% for the first time. Q2 at 9.93% vs. prior quarter 10.13%. This is not a one-quarter blip; it reflects a structural shift in funding: priority-sector PTCs are pricing at ~8% (highest demand among private and foreign banks), CRISIL AA+ rating is giving funding access, and the company has negotiation leverage. This is the single most important near-term win because it offsets the 25 basis-point rate hike already passed and preserves margin guidance even if rates rise further.
Collection efficiency is holding despite monsoon. October collections hit 99.2% (up from 98.1% in Q2) despite El Niño-driven drought stress in Maharashtra and Karnataka. This is the acid test for the company's claim that 81% NATCAT insurance and disciplined collection practices are working. If collections had cracked under monsoon pressure, it would signal that asset quality guidance is optimistic. They didn't.
Where the stock sits vs. fundamentals
Price action and positioning: The stock at ₹161.62 is trading −42.48% from its all-time high of ₹281. It sits above its 52-week low of ₹134.11 (+20.51%) but below key moving averages (SMA50 ₹174.19, SMA200 ₹188.2). RSI at 50.4 is neutral — no momentum either way. Volume is normal; no panic selling or accumulation visible. This is not a crash; it's a repricing.
Ownership stable, no insider dumps. FII holdings at 23.12% (up 0.3 bps from Q1), DII 3.38%, promoter 55.47% (steady). FII have trimmed modestly over the past year (from 25.47% a year ago to 23.12% now), suggesting institutional sellers have been patient, not panicked. No recent block/bulk trades flagged. This is the market working through a re-rating, not a fundamental collapse.
The bull-bear ledger
BULL: All guidance metrics on track or beaten (AUM 22% vs 20%, NIM 12.5%, CoF below 10%, credit cost 2.6%)
BULL: Cost of funds breakthrough (9.93%) offsets rate hikes and protects margin guidance
BULL: Portfolio diversification visible (27% individual loans, ₹453 Cr gold, ₹100+ Cr micro LAP) — the building blocks of ₹30K AUM 2030 thesis
BULL: Collection efficiency holding (99.2% Oct vs 98.1% Q2) despite monsoon stress — validates NATCAT/collection playbook
BEAR: New product portfolios are early-stage: 18-month seasoning on micro LAP, 27% AUM shift to individual loans. Delinquency (90+ at 0.02%) is reassuring but untested in stress.
BEAR: Geographic concentration risk not fully hedged: 3.6% on-book in affected states, 81% NATCAT insured but 19% uninsured. Rising rate cycle + monsoon stress could compress collections.
BEAR: H2 needs ₹233–258 Cr PAT to hit FY guidance (₹425–450 Cr). Q1 normal seasonality + Q2 strong sets a high bar for H2. Any miss on H2 guidance signals execution or macro headwinds.
BEAR: Rate cycle headwind: 25 bps hike passed, refinancing risk on co-terminus loans. CoF at 9.93% is a win, but if rates rise further, margin compression risk.
Risks, ranked by how much they should concern a holder
New portfolio delinquency emergence (individual loans, micro LAP, gold loans)
Medium27% AUM is now in individual loans, a 18-month-old cohort with 0.02% 90+ NPA. Gold and micro LAP are even earlier. Delinquency could emerge slowly over next 6–8 quarters. If it does, credit cost guidance of <2.7% is at risk, and NIM compression follows.
Rate cycle + monsoon compound margin pressure
Medium25 bps hike passed; further hikes likely. CoF is at 9.93% but refinancing risk exists on co-terminus loans. Monsoon stress (El Niño) in Maharashtra/Karnataka (3.6% on-book) could drive collections dips and delinquency if drought persists. Together, these could pressure NIM beyond guidance.
H2 execution — closing the PAT gap
MediumH1 PAT ₹192 Cr vs FY target ₹425–450 Cr means H2 needs ₹233–258 Cr (seasonal uplift expected). If H2 disappoints, guidance misses and raises questions about disbursement/collections/margins. Early warning for 2030 thesis.
Regulatory headwinds (CGFMU budget, IRDAI draft)
LowCGFMU credit guarantee budget allocation pending; IRDAI draft regulation in feedback stage. Insurance revenue is <5% of total, so even if constrained, earnings impact is capped. But timing uncertainty can rattle sentiment.
What to watch next
1 · Q3 collections and new-product delinquency
November and December collections will test the monsoon claim. If 99%+ holds, it validates the NATCAT/collection playbook. Any dip signals hidden leverage in new portfolios. Individual loan and micro LAP 90+ NPA must stay near zero.
2 · H2 PAT trajectory — the ₹233–258 Cr hurdle
If Q3+Q4 deliver ₹233–258 Cr combined, FY guidance is intact and the bull case holds. If H2 under-delivers, it flags either execution slippage or macro headwinds the company underestimated. This is the single number to track.
3 · Cost of funds stability — 9.93% is not a given
If CoF stays below 10% despite further rate hikes, it's a big win. If it bounces back to 10%+, margin guidance is at risk and the market reprices lower. Watch for PTC transaction rates and NCD placement spreads.
The honest read
Muthoot Microfin's Q2 is a steady quarter executed well. Every major guidance metric is on track or beaten. The company has cracked cost of funds below 10%, portfolio diversification is accelerating, and collections are holding under monsoon stress. Management quality is high (Q&A direct, execution track record strong, very few deflections). The ₹30,000 Cr AUM / 5% ROA by 2030 thesis is credible if the company can: (1) seasoning new products successfully (individual loans, gold, micro LAP), (2) navigate the rate cycle without margin compression, and (3) keep geographies diversified and collections stable through monsoon volatility.
But the stock trading 42% off its all-time high and below key moving averages is the market's way of saying: we believe the execution roadmap, but we're not paying premium multiples until we see delinquency data on new products and proof that margins can hold through a rising-rate cycle and geographic stress. That's a reasonable market read. This is a 'show me' moment, not a 'trust me' moment.
For a holder: The quarter is clean, guidance is intact, and Q3/Q4 will answer the key questions (collections, new-product delinquency, H2 pacing). The risk is not binary — it's a mosaic of monsoon/rate/execution risks that are manageable but not negligible. The stock is fairly priced for a 'prove-it' story, not a home-run story.
The number to track from here: H2 PAT delivery (target ₹233–258 Cr). If that lands, the bull case is gaining traction. If it misses, re-rate lower.
Muthoot Microfin delivered a strong, well-executed Q2 — all guidance metrics on track, margin expanded to upper guidance end, cost of funds cracked below 10%, collection efficiency holding through monsoon. This is steady-state execution, not a step-change. The market has repriced the stock 42% lower from ATH, waiting for evidence that new portfolios season well, margins hold through rising rates, and H2 closes the PAT gap credibly. That's a fair ask. Watch Q3 collections, new-product delinquency, and H2 PAT pacing to know whether the market is about to re-rate up or confirm the caution is warranted.